Felix Beacher, Dionysia Patrinou, and Sharjeel Ahmad[email protected]AIECR 2022 Rewind: AI advances are tops among trends on displayFollowing two gloomy years absorbed by COVID-19, the ECR returned to an in-person event this year. Analysts from market research firm Omdia offer an analysis of the top trends at ECR 2022.July 27, 2022Page 1 of 1Top StoriesMRIPI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRIPI-RADS v2.1 was developed by the ACR and the European Society of Urogenital Radiology (ESUR) and released in 2019.UltrasoundqHDMI differentiates radial scars from invasive breast cancerInterventionalLung biopsy before surgery linked to cancer recurrenceCTAbnormal CT-FFR results translate to up to 7 years of cardiovascular riskSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar